Second-generation tricyclic pyrimido-pyrrolo-oxazine mTOR inhibitor with predicted blood-brain barrier permeability
Date Issued
2021-01-01
DOI
10.1039/d0md00408a
Abstract
Highly selective mTOR inhibitors have been discovered through the exploration of the heteroaromatic ring engaging the binding affinity region in mTOR kinase. Compound 11 showed predicted BBB permeability in a MDCK-MDR1 permeability in vitro assay, being the first pyrimido-pyrrolo-oxazine with potential application in the treatment of neurological disorders.
File(s)![Thumbnail Image]()
Loading...
Name
20210617104845_60cb0c6d4f13d.pdf
Size
1.88 MB
Format
Adobe PDF
Checksum
(MD5):d8777295ab3c1269308bbbe670fa9587